ATP-sensitive potassium channels (KATP) are involved in the regulation of potassium homeostasis in the nervous system, and they may play an important role in acute peripheral nerve and spinal cord injury. Here, the expression of the KATP genes was monitored by reverse transcription polymerase chain reaction (RT-PCR) in the rat dorsal root ganglion, spinal cord and cerebral cortex following acute sciatic nerve and spinal cord injury. Electrophoresis of the RT-PCR products showed that in comparison with the normal rats, the KATP mRNA expression level was up-regulated for the Kir6.2 subunit in the rat dorsal root ganglion 4 and 24 h after the acute sciatic nerve injury (142.7 ± 23.0 and 135.5 ± 21.0%, p < 0.05, vs. control, n = 3), and both Kir6.1 and sulphonylurea receptor 2 mRNA were increased in the spinal cord during the same time period after the acute spinal cord injury (266.5 ± 67.1 and 248.7 ± 67.7%; 145.1 ± 42.6 and 152.6 ± 44.3%, p < 0.05, vs. control, n = 3). No significant changes of KATP genes were observed in the cerebral cortex among both sciatic-nerve- and spinal-cord-injured animals. These results suggest that acute peripheral nerve and spinal cord injury provoke different regulations of KATP gene expression in the peripheral and central nervous system.

Keywords:
ATP-sensitive potassium channel, mRNA expression, Dorsal root ganglion, Spinal cord, Cerebral cortex
1.
Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, Schwab ME: Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995;378:498–501.
2.
Schnell L, Schwab ME: Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990;343:269–272.
3.
Schnell L, Schwab ME: Sprouting and regeneration of lesioned corticospinal tract fibres in the adult rat spinal cord. Eur J Neurosci 1993;5:1156–1171.
4.
Z’Graggen WJ, Metz GA, Kartje GL, Thallmair M, Schwab ME: Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci 1998;18:4744–4757.
5.
Bregman BS, Kunkel-Bagden E, Reier PJ, Dai HN, McAtee M, Gao D: Recovery of function after spinal cord injury: mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Exp Neurol 1993;123:3–16.
6.
David S, Aguayo AJ: Axonal elongation into peripheral nervous system ‘bridges’ after central nervous system injury in adult rats. Science 1981;214:931–933.
7.
Li Y, Field PM, Raisman G: Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 1997;277:2000–2002.
8.
Mori F, Himes BT, Kowada M, Murray M, Tessler A: Fetal spinal cord transplants rescue some axotomized rubrospinal neurons from retrograde cell death in adult rats. Exp Neurol 1997;143:45–60.
9.
Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J: Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 2000;25:425–435.
10.
Richardson PM, McGuinness UM, Aguayo AJ: Axons from CNS neurons regenerate into PNS grafts. Nature 1980;284:264–265.
11.
Tessler A, Fischer I, Giszter S, Himes BT, Miya D, Mori F, Murray M: Embryonic spinal cord transplants enhance locomotor performance in spinalized newborn rats. Adv Neurol 1997;72:291–303.
12.
Tuszynski MH, Weidner N, McCormack M, Miller I, Powell H, Conner J: Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination. Cell Transplant 1998;7:187–196.
13.
Xu XM, Chen A, Guenard V, Kleitman N, Bunge MB: Bridging Schwann cell transplants promote axonal regeneration from both the rostral and caudal stumps of transected adult rat spinal cord. J Neurocytol 1997;26:1–16.
14.
Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH: Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J Neurosci 1999;19:3556–3566.
15.
Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH: Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 1997;17:5560–5572.
16.
Liu Y, Kim D, Himes BT, Chow SY, Schallert T, Murray M, Tessler A, Fischer I: Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 1999;19:4370–4387.
17.
Schnell L, Schneider R, Kolbeck R, Barde YA, Schwab ME: Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 1994;367:170–173.
18.
Tuszynski MH, Gabriel K, Gage FH, Suhr S, Meyer S, Rosetti A: Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury. Exp Neurol 1996;137:157–173.
19.
Ye JH, Houle JD: Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp Neurol 1997;143:70–81.
20.
Kwon BK, Tetzlaff W: Spinal cord regeneration: from gene to transplants. Spine 2001;26:S13–S22.
21.
McDonald JW, Sadowsky C: Spinal-cord injury. Lancet 2002;359:417–425.
22.
Liss B, Roeper J: Molecular physiology of neuronal K-ATP channels. Mol Membr Biol 2001;18:117–127.
23.
Seino S: ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 1999;61:337–362.
24.
Sakura H, Ammala C, Smith PA, Gribble FM, Ashcrof FM: Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle. FEBS Lett 1995;377:338–344.
25.
Ishida T, Yarimizu K, Gute DC, Korthuis RJ: Mechanisms of ischemic preconditioning. Shock 1997;8:86–94.
26.
Perez-Pinzon MA, Born JG: Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C. Neuroscience 1999;89:453–459.
27.
Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15–26.
28.
Dunn-Meynell AA, Rawson NE, Levin BE: Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain. Brain Res 1998;814:41–54.
29.
Zhou M, Tanaka O, Sekiguchi M, Sakabe K, Anzai M, Izumida I, Inoue T, Kawahara K, Abe H: Localization of the ATP-sensitive potassium channel subunit (Kir6. 1/uKATP-1) in rat brain. Brain Res Mol Brain Res 1999;74:15–25.
30.
Karschin C, Ecke C, Ashcroft FM, Karschin A: Overlapping distribution of KATP channel-forming Kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain. FEBS Lett 1997;401:59–64.
31.
Yamada M, Isomoto S, Matsumoto S, Kondo C, Shindo T, Horio Y, Kurachi Y: Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. J Physiol 1997;499:715–720.
32.
Clement IV JP, Kunjilwar K, Gonzalez G, Schwanstecher M, Panten U, Aguilar-Bryan L, Bryan J: Association and stoichiometry of KATP channel subunits. Neuron 1997;18:827–838.
33.
Inagaki N, Gonoi T, Seino S: Subunit stoichiometry of the pancreatic beta-cell ATP-sensitive K+ channel. FEBS Lett 1997;409:232–236.
34.
Shyng S, Ferrigni T, Nichols CG: Control of rectification and gating of cloned KATP channels by the Kir6.2 subunit. J Gen Physiol 1997;110:141–153.
35.
Zerangue N, Schwappach B, Jan YN, Jan LY: A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channels. Neuron 1999;22:537–548.
© 2007 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.